Trials / Completed
CompletedNCT00292734
STILDEP: Zolpidem in Depressive and Dysthimic Patients
Additive Beneficial Effect of Zolpidem Onto the Antidepressant Therapy in Depressive and Dysthimic Patients in the Acute Phase of the Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective: To show that the combination of Zolpidem + antidepressant therapy is more effective in the treatment of the secondary insomnia of depressive and dysthimic patients than antidepressant therapy alone in the acute phase of the disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zolpidem |
Timeline
- Start date
- 2005-01-01
- Completion
- 2006-06-01
- First posted
- 2006-02-16
- Last updated
- 2007-12-06
Locations
1 site across 1 country: Hungary
Source: ClinicalTrials.gov record NCT00292734. Inclusion in this directory is not an endorsement.